A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin
Clinical trial NCT00456053 · COMPLETED
Trial details
- NCT number
- NCT00456053
- Sponsor
- Kyntra Bio
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.